StonvexLoading…
StonvexStonvexStonvexCore line items from ARKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $77.33M | $40.75M | $165.75M | $128.43M |
Operating Income | $-563.00K | $1.09M | $-4.06M | $-2.34M |
Net Income | $-912.00K | $896.00K | $-11.47M | $-9.55M |
EPS (Diluted) | $-0.25 | $0.25 | $-3.18 | $-2.65 |
Total Assets | $131.76M | $130.44M | $133.50M | $136.34M |
Total Liabilities | $100.46M | $97.34M | $101.39M | $102.15M |
Cash & Equivalents | $11.49M | $9.14M | $11.32M | $12.32M |
Free Cash Flow OCF − CapEx | $-3.90M | $-1.80M | $-1.50M | $-506.00K |
Shares Outstanding | 3.61M | 3.61M | 3.61M | 3.61M |